A Healthy Volunteer Study to Assess the Relative Bioavailability of 2 Forms of SB773812 Tablets.

NCT00500201 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: SB- 773812 60 mg
DRUG: SB- 773812 120 mg
DRUG: Placebo

Sponsor

GlaxoSmithKline